About UsManagement Team
Board of Directors
Advisory Board

Advisory Board:


Steven Stice, PhD

Dr. Stice is a University of Georgia Research Alliance Eminent Scholar and the Director of the University of Georgia Regenerative Bioscience Center. He has an extensive background in animal health technology and stem cell applications along with an entrepreneurial record of successful companies generated from IP he developed. Dr. Stice was a co-founder and former Chief Scientific Officer at Advanced Cell Technology, Inc., a stem cell company with a market cap of $150 million. His current research activities are varied including working with the Bill and Melinda Gates Foundation to develop disease resistant livestock and developing stem cell therapies for Stroke and Parkinson’s. He has published and lectured internationally on stem cells throughout his career, with research findings highlighted in the NY Times, USA Today, Time Magazine, CNN, CBS, NBC and ABC News broadcasts.

Bob Guldberg, PhD

Dr. Guldberg is a Professor of Mechanical Engineering and Biomedical Engineering at the Georgia Institute of Technology and holds the Parker H. Petit Director's Chair in Bioengineering and Bioscience.  He has published over 150 book chapters and journal articles focused on musculoskeletal growth and development, functional regeneration following traumatic injury, and degenerative diseases, including skeletal fragility and osteoarthritis.  In November 2009, he was appointed Executive Director of the Institute for Bioengineering and Bioscience at Georgia Tech after serving as Associate Director since 2004.  Dr. Guldberg is a Fellow of the American Institute for Medical and Biological Engineering and also currently serves as Chair of the Musculoskeletal Tissue Engineering Study Section at NIH and Chair of the Americas Chapter of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AM).


  Patrick West
Patrick West is a Partner at Mirus Capital Advisors. He is an accomplished executive, entrepreneur, advisor and director with executive management and M&A experience in the healthcare technology and oil and gas / manufacturing sectors. Patrick spent 10 years with global orthopedic device manufacturer Stryker Corporation in various positions culminating in VP of Global Sales and Marketing for Stryker Biotech. He then founded MaxTorque, which he led as CEO through exit in 2009 to Cameron International at best in industry multiples. Subsequent to this exit, he held a number of non-executive board positions in Europe highlighted by helping to guide the sale of Orthomimetics Ltd. at one of the most successful small-cap exits worldwide to Tigenix NV. Patrick holds a bachelor’s degree from DePauw University and has participated in the executive management training program at Harvard Business School.

John Peroni, DVM, DACVS

Dr. Peroni is an Associate Professor in Large Animal Surgery at the University of Georgia and Chairman of the North American Veterinary Regenerative Medicine Association. His publications include several textbook chapters on stem cell therapies in horses and he has spent the past three years implementing regenerative therapies with a focus on fracture repair in animals.